In 2023, medical cannabis in Europe is expected to generate around *** million euros in unlicensed sales. By 2027, unlicensed medical cannabis sales are forecasted to reach **** billion euros. This statistic illustrates an unlicensed sales forecast for medical cannabis in Europe from 2023 to 2027.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Prohibition Partners. (April 6, 2023). Unlicensed sales forecast of medical cannabis in Europe from 2023 to 2027 (in billion euros) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 31, 2026, from /statistics/1306931/forecast-medical-cannabis-unlicensed-sales-europe/
Prohibition Partners. "Unlicensed sales forecast of medical cannabis in Europe from 2023 to 2027 (in billion euros)." Chart. April 6, 2023. ÌÇÐÄÆÆ½â°æ. Accessed July 31, 2026. /statistics/1306931/forecast-medical-cannabis-unlicensed-sales-europe/
Prohibition Partners. (2023). Unlicensed sales forecast of medical cannabis in Europe from 2023 to 2027 (in billion euros). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 31, 2026. /statistics/1306931/forecast-medical-cannabis-unlicensed-sales-europe/
Prohibition Partners. "Unlicensed Sales Forecast of Medical Cannabis in Europe from 2023 to 2027 (in Billion Euros)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 6 Apr 2023, /statistics/1306931/forecast-medical-cannabis-unlicensed-sales-europe/
Prohibition Partners, Unlicensed sales forecast of medical cannabis in Europe from 2023 to 2027 (in billion euros) ÌÇÐÄÆÆ½â°æ, /statistics/1306931/forecast-medical-cannabis-unlicensed-sales-europe/ (last visited July 31, 2026)
Unlicensed sales forecast of medical cannabis in Europe from 2023 to 2027 (in billion euros) [Graph], Prohibition Partners, April 6, 2023. [Online]. Available: /statistics/1306931/forecast-medical-cannabis-unlicensed-sales-europe/